More than 95 percent of people who screen positive for lung cancer don’t actually have it, but AI could change that.
Drs. Frank Sciurba and Roy Semaan in the Division of Pulmonary, Allergy and Critical Care Medicine treated the first two patients in an Early Feasibility Study of an electrosurgical system created to treat the persistent symptoms of chronic bronchitis.
Globin Solutions, Inc., a startup biotechnology company formed last year by scientists from the University of Pittsburgh, completed over $5 million in Series A funding for its development of an antidote to carbon monoxide poisoning.
Abstracts and Registration are now open for the Pittsburgh International Lung Conference being held at the University Club on October 4-5, 2018.